Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
A synthetic small molecule with the chemical formula C14H16ClN3 and a molecular weight of approximately 261.75 g/mol. It is classified as a phenylpyrazole derivative, containing both a pyrazole ring and a piperidine moiety substituted with a para-chlorophenyl group. The compound has been described in chemical databases as an experimental agent, but it is not approved for medical use in any jurisdiction. According to DrugBank, its mechanism of action is listed as "prothrombin inhibitor," suggesting potential anticoagulant activity via inhibition of prothrombin (coagulation factor II), though there are no clinical indications or trials reported for this compound[6]. No marketed products or therapeutic uses are documented.
- Other names
- 156336-70-84-[5-(4-chlorophenyl)-1H-pyrazol-3-yl]piperidine4-(5-(4-chlorophenyl)-1H-pyrazol-3-yl)piperidine4-(3-(4-Chlorophenyl)-1H-pyrazol-5-yl)piperidine
02
Targets
F2 (Thrombin)
Beyond the preview
Go deeper on 4-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidine.